SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-374182
Filing Date
2013-09-23
Accepted
2013-09-23 10:01:55
Documents
3
Period of Report
2013-09-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d598849d8k.htm 8-K 15270
2 EX-99.1 d598849dex991.htm EX-99.1 9888
3 GRAPHIC g598849g46r34.jpg GRAPHIC 12230
  Complete submission text file 0001193125-13-374182.txt   43403
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19825 | Film No.: 131109281
SIC: 2834 Pharmaceutical Preparations